Company Research Report: City of Hope

Company Overview

• Name: City of Hope

• Mission of the Company: To make hope a reality for all touched by cancer and diabetes, by tailoring a combination of cancer treatments to the needs of each individual patient through scientific discovery, clinical ingenuity, and compassion.

• Founded & By Whom: Founded in 1913 by the Jewish Consumptive Relief Association, a group of volunteers committed to helping those afflicted with tuberculosis.

• Key People in the Company:

• Anita Johnson, MD, FACS: Chief of Surgery, City of Hope Atlanta; Leader, City of Hope Atlanta Women’s Cancer Center

• Tulio Rodriguez, MD: Director of Hematology, Bone Marrow Transplant, and Cellular Therapy Program, City of Hope Chicago

• Toufic Kachaamy, MD: Chief of Medicine, City of Hope Phoenix

• Headquarters: No specific headquarters is mentioned.

• Number of Employees: More than 11,000 employees including researchers, associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers, and support staff.

• Revenue of the Company: No information is available.

• What is the Company Known For: Being a world leader in cancer research, treatment, prevention, and development of significant medical advancements like the first synthetic human insulin and the technology behind various cancer-fighting drugs.

Products

• Products Offered: City of Hope offers personalized cancer care, including genomic testing and precision treatment, along with state-of-the-art medical technologies.

• High-Level Description of the Products: The emphasis is on delivering comprehensive personalized cancer treatments alongside supportive therapies that manage side effects.

• Key Features of Each of the Products:

• Advanced genomic testing

• State-of-the-art technologies

• Evidence-informed supportive care therapies

• Personalized treatment plans designed by cancer experts

Recent Developments

• Recent Developments in the Company:

• City of Hope became a part of the National Cancer Institute's comprehensive cancer centers and united with the Cancer Treatment Centers of America (CTCA) to form a national cancer research and treatment system.

• New Products Launched: No information on new products launched is available.

• New Features Added to Existing Products: No specific new features are mentioned.

• Any New Partnerships, etc.:

• Joined forces with Cancer Treatment Centers of America for a shared vision.

• City of Hope Cancer Center Atlanta joined the Georgia Hospital Association and the Georgia Alliance of Community Hospitals to promote accessible and equitable health care in Georgia.

• Introduced several new medical professionals to lead expansions, such as Dr. Amy Chen and Dr. Joannie M. Ivory in Atlanta.

Locations and Network

• Locations:

• Atlanta: Cancer Center, 600 Celebrate Life Parkway, Newnan, Georgia 30265

• Chicago: Cancer Center, 2520 Elisha Avenue, Zion, Illinois 60099

• Duarte: Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, California 91010

• Orange County: Lennar Foundation Cancer Center, 1000 FivePoint, Irvine, California 92618

• Phoenix: Cancer Center, 14200 W. Celebrate Life Way, Goodyear, Arizona 85338

Historical Context and Achievements

• Historical Milestones:

• 1913: Founded to support tuberculosis patients.

• Developed the "cobalt bomb" for radiation therapy in 1955.

• Played a significant role in the development of the first synthetic human insulin in 1978.

• National Cancer Institute designated City of Hope as a comprehensive cancer center in 1998.

• Achieved Magnet® recognition from the American Nurses Credentialing Center in 2021.

• Impact: City of Hope has historically led cancer research and treatment innovations, contributing significantly to modern medicine and patient care.